NEW YORK, Aug. 06, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of Aimmune Therapeutics, Inc. (Nasdaq:AIMT) commenced on The Nasdaq Stock Market on August 6, 2015.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c653e192-de28-4132-bea3-2255ad990923
Aimmune Therapeutics, Inc., founded in 2011 as Allergen Research Corporation (ARC), is a clinical-stage biopharmaceutical company developing treatments for peanut allergy and other food allergies. The company’s characterized oral desensitization immunotherapy (CODIT™) system uses rigorously characterized product candidates with gradual, controlled up-dosing protocols to obtain clinically meaningful desensitization to food allergens.
“Aimmune Therapeutics is working to address the unmet need to protect people with prevalent food allergies from the dangers of exposure to their allergens,” said Nelson Griggs, Executive Vice President, Listing Services, Nasdaq. “We are excited to welcome Aimmune Therapeutics to the Nasdaq family and congratulate them on their initial public offering.”
By listing with Nasdaq, Aimmune Therapeutics, Inc. joins some of the world’s largest and most revolutionary healthcare companies. Nasdaq is the exchange of choice to over 77 percent of health care companies listed on U.S. markets.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $9.1 trillion and more than 10,000 corporate clients. To learn more, visit http://nasdaq.com/ambition or http://business.nasdaq.com.
Source:The NASDAQ OMX Group, Inc.